Valeant¶Ç°â²´¬ì¤â³N²£«~·~°È
¡i©ú³ø±M°T¡j´^³Õ³q°TªÀ¤Þzª¾±¡ªÌ»¡¡A¥[®³¤j»sÃĶ°¹ÎValeant Pharmaceuticals International(¥N¸¹VRX)¬¢½Í¤@©v¥æ©ö¡A¦³·N¥X°â¥¦ªºBausch & Lomb¤À³¡¤â³N²£«~·~°Èµ¹¼w°êÂåÀø¬ì§Þ¤½¥qCarl Zeiss Meditec AG¡C
°Î¦W®ø®§¨Ó·½»¡¡AÂù¤è¤´¦b¬¢°Ó¶¥¬q¡A¥i¯àÁÙ¦³¼Æ©P¡A¤~·|¹F¦¨¨óij¡Cª¾±¡ªÌÁÙ»¡¡A¤]³\ÁÙ¦³§Oªº¶R®a¡A¦³¿³½ì¬¢½Í¥Í·N¡C
¾Ú±x¡AValeant²´¬ì¤â³N¾¹§÷·~°Èªº°â»ù¥i¯à¹F¨ì20»õ¬ü¤¸¡C¥Ø«e¡A¶R½æÂù¤è¥¼¦³³Ì«á©w®×¡A¥æ©ö¨óij©Î³\¤£¯à¹F¦¨¡C
Valeant»PCarl Zeiss Meditec¥Nªí³£¤£ªÖµû½×³o¨Æ¡A®ø®§¶Ç¥X«á¡AÁ`³¡¦b»í¥_§J¬ÙªºValeant©P¤G¦b¦hÛ¦hÃÒ¨é¥æ©ö©ÒªÑ»ù¤@«×Ãk¤É¨ì17.31¤¸¡A¼W´T3.9%¡A³Ì«á¤W¤É6.21¤¸¡A©Î1.26%¡A¦¬³ø16.87¤¸¡C
¥«È¹F41»õ¼Ú¤¸¡A§é¦X46»õ¬ü¤¸ªºCarl Zeiss Meditec¡A¬OCarl ZeissªºÂåÀø³]¬I·~°È¤À³¡¡CCarl Zeiss¬O¼w°ê¬ì¾Ç¤u¨ã»P»ö¾¹»s³y¤½¥q¡A¦³170¦h¦~¾ú¥v¡C°£¤FÂåÀø³]³Æ¡AZeissÁÙ»s³y´ú¶q¬ì§Þ²£«~¡NÅã·LÃè¡N²´Ãè¤ù¡N·Ó¬Û¾÷¡N¹q¼vÃèÀY¡N±æ»·Ãè©M¥b¾ÉÅé»s³y¾¹§÷¡C
Valeant¦æ¬FÁ`µô©¬©¬(Joe Papa)¬°¤F«d´î289»õ¬ü¤¸¶Å¶µ¡An¥X°â¸ê²£®M²{¡C¦b¹L¥h¨â¦~¡AValeant¨ü²Ö©ó³¡¤ÀÃöÁäÃĪ«ªº¤£²z·Q¾P±¡¡A¥H¤Î¬ü°ê¬F©²¹ï¥¦ªºÃĪ«q»ù½Õ¬d¡AÀç¹B³B©ó§x¹Ò¡A©¬©¬¤O¹Ï§áÂàÀZ¶Õ¡C
Valeant¤W¤ë¹w´ú¡A¸g¹L¸g½Õ¾ã«á¡A¥¦ªº¥þ¦~¬Õ§Q¥i¯à°ª¹L¦¹«e¦ôºâ¼Æ¦r¡A¨Ã»¡¶°¹Î¤w¨ú±o¶i®i¡A³z¹L¤@³s¦ê¥æ©ö«d´îÃe¤jt¶Å¡C
®ø®§¨Ó·½¦¦b¥h¦~12¤ë³zÅS¡AValeant»P¼ç¦b¶R®a¬¢½Í¥Í·N¥¢±Ñ¡A¥h¦~©ñ±ó¥X°âºX¤USalix¸zGÃĪ«¤À³¡p¹º¡C1Ó¤ë«á¡AValeant¦P·N¥H¨â¶µ¥æ©ö¥X°â21»õ¬ü¤¸¸ê²£¡A§â3Ó¥Ö½§Å@²z«~µP½æµ¹¤ÆùÛ«~¥¨À¼L'Oreal¡A¨Ã§â¨äDendreon PharmaceuticalsÃĪ«¤À³¡°â¤©¤¤°ê¤TM¶°¹Î¡C